Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Ramiz A. Boulos"'
Autor:
Berkay Ozcelik, Paul Pasic, Parveen Sangwan, Cheang Ly Be, Veronica Glattauer, Helmut Thissen, Ramiz A. Boulos
Publikováno v:
ACS Omega, Vol 5, Iss 18, Pp 10288-10296 (2020)
Externí odkaz:
https://doaj.org/article/5a6921f21c06463d8e51477f54cd00f4
Autor:
Helmut Thissen, Veronica Glattauer, Cheang Ly Be, Parveen Sangwan, Paul Pasic, Ramiz A. Boulos, Berkay Ozcelik
Publikováno v:
ACS Omega
ACS Omega, Vol 5, Iss 18, Pp 10288-10296 (2020)
ACS Omega, Vol 5, Iss 18, Pp 10288-10296 (2020)
Ventilator-associated pneumonia (VAP) is a highly common hospital-acquired infection affecting people that require mechanical ventilation. The endotracheal tube (ETT) used during the ventilation process provides a surface that can allow bacterial col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6fbb23ba648fd43f583ce11d8e93371
http://europepmc.org/articles/PMC7226855
http://europepmc.org/articles/PMC7226855
Autor:
Justin M. Chalker, Xianjue Chen, Darryl Jones, Ramiz A. Boulos, Bedia S Al Harbi, Kasturi Vimalanathan, Wei Zhang, Jamie S. Quinton, Matt Jellicoe, Aghil Igder, Ibrahim K Alsulami, Keith A. Stubbs, Colin L. Raston, Xuan Luo, Thaar M. D. Alharbi
Induced mechanical energy in a thin film of liquid in an inclined rapidly rotating tube in the vortex fluidic device (VFD) can be harnessed for generating non-equilibrium conditions, which are optimal at 45o tilt angle, but the nature of the fluid fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af0a56139103628d47e00e712a68cc0c
https://doi.org/10.26434/chemrxiv.13141352
https://doi.org/10.26434/chemrxiv.13141352
Publikováno v:
Drug Development and Industrial Pharmacy. 44:1451-1457
© 2018 Informa UK Limited, trading as Taylor & Francis Group Objective: Novel antibiotic Ramizol ® is advancing to clinical trials for the treatment of gastrointestinal Clostridium difficile associated disease. Despite this, previous studies have s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac496f713e5a3dd26c2cf27bda0a7478
https://doi.org/10.1080/03639045.2018.1459676
https://doi.org/10.1080/03639045.2018.1459676
Autor:
Jayson X. Chen, Katherine Sibley, Janice A. Lansita, Odete Mendes, Lee Koetzner, Amy Kimzey, Ramiz A. Boulos
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Drug resistant bacteria are winning the fight over antibiotics with some bacteria not responding to any antibiotics, threatening modern medicine as we know it. The development of new, effective and safe antibiotics is critical for addressing this iss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::715f7ecf7236c01fe37dadfc93485756
http://europepmc.org/articles/PMC6336794
http://europepmc.org/articles/PMC6336794
Autor:
Lynn Miesel, Clive A. Prestidge, Dean L Shinabarger, Deb Sweeney, Ramiz A. Boulos, Shasha Rao
Publikováno v:
The Journal of Antibiotics
Antibiotic-resistant bacteria is a major threat to human health and is predicted to become the leading cause of death from disease by 2050. Despite the recent resurgence of research and development in the area, few antibiotics have reached the market
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fb3ccbe8df6bd46fb14701867c5d60
https://doi.org/10.1038/ja.2016.45
https://doi.org/10.1038/ja.2016.45
Autor:
Alexa Dinant, Ramiz A. Boulos
Publikováno v:
Drug Design, Development and Therapy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73644615975d137bd2a5b40fa7c3d33
http://europepmc.org/articles/PMC4809335
http://europepmc.org/articles/PMC4809335
Publikováno v:
IndraStra Global.
This manuscript version is made available under the CC-BY-NC-ND 4.0 license: http://creativecommons.org/licenses/by-nc-nd/4.0/ which permits use, distribution and reproduction in any medium, provided the original work is properly cited. This author a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078a96cf5cea396966d5847076a67209
https://igi.indrastra.com/items/show/93105
https://igi.indrastra.com/items/show/93105
Publikováno v:
Drug development and industrial pharmacy. 44(9)
Novel antibiotic RamizolThe development of new antibiotic treatments will help in combatting the rising incidence of antimicrobial resistance.RamizolFormulation technique showed major influence on particle size and loading levels with optimal loading
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e1c58d10eb88d91797ad05b71a8d6a8
https://pubmed.ncbi.nlm.nih.gov/29619851
https://pubmed.ncbi.nlm.nih.gov/29619851
Autor:
Uwe H. Stroeher, Edwin S. Tjandra, Colin L. Raston, Nick van Holst, Frederick M. Ausubel, Soumya Ramu, Johnny X. Huang, Annie L. Conery, Mark A. T. Blaskovich, Christopher T. Gibson, Ashley D. Slattery, Ian M. Orme, Mark E. Cooper, Andrés Obregón-Henao, Melissa H. Brown, Irene R Iscla, Jonah Larkins-Ford, Paul Blount, Robin Wray, Angela M. Kavanagh, Cindy Macardle, Ramiz A. Boulos, Chee Ling Tong
Publikováno v:
The Journal of Antibiotics
The growing problem of antibiotic-resistant bacteria is a major threat to human health. Paradoxically, new antibiotic discovery is declining, with most of the recently approved antibiotics corresponding to new uses for old antibiotics or structurally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ce39d18d06e5eb2df942c32dcd190c
http://europepmc.org/articles/PMC4430313
http://europepmc.org/articles/PMC4430313